The levels of GSH, GPX4, Nrf2, and Keap1 were distinctly reduced in active RA patients than in healthy ones, while the levels of these proteins were clearly higher in RA patients in remission than in active RA patients. This evidence concerns the gene NFE2L2 and rheumatoid arthritis.